Lake State Street Capital upgraded RCEL Avita's nasdaq listed version from $30USD to $40USD Thursday Night AEST, at close RCEL was $20.79USD. This resulted in the large upswing today Friday.

"VITA Medical, Inc. (NASDAQ:RCEL – Get Free Report)’s share price hit a new 52-week high during trading on Thursday after Lake Street Capital raised their price target on the stock from $30.00 to $40.00. The company traded as high as $20.14 and last traded at $20.00, with a volume of 440691 shares changing hands. The stock had previously closed at $17.27.

A number of other equities analysts also recently weighed in on RCEL. Cantor Fitzgerald assumed coverage on AVITA Medical in a research report on Tuesday, June 27th. They set an “overweight” rating and a $23.00 price target for the company. BTIG Research raised their price target on AVITA Medical from $19.00 to $26.00 in a research note on Tuesday, June 20th. Finally, Piper Sandler increased their price objective on AVITA Medical from $16.00 to $18.50 in a report on Friday, May 12th."